Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

J&J Gains on Lifting Forecast Even as Vaccine Sales Seen Unchanged

Stock MarketsOct 19, 2021 07:13AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters

By Dhirendra Tripathi

Investing.com – Johnson & Johnson stock (NYSE:JNJ) rose 1% in Tuesday’s premarket as the company nudged up its annual profit forecast while keeping its outlook for Covid vaccine sales for the year unchanged.

The company now sees its annual adjusted earnings to be around $9.79 per share, up some 1.4% from a prior estimate of $9.65 at center of the guidance range.

J&J in July said it expects to produce between 500 million and 600 million doses of its one-shot vaccine this year, pretty much half of its previous target of making a billion. Production and quality issues at a manufacturing site set the company back in rolling out its Covid vaccines faster.

The forecast revision follows third-quarter results that saw the consumer and pharmaceutical giant beat estimates for profit but fall short on sales.

Sales in the pharmaceuticals business, which contribute more than half of the company’s revenue, rose the most, by 14% on an adjusted basis. Medications against cancer, hypertension, immune-mediated inflammatory diseases, psoriatic arthritis and plaque psoriasis were in demand.

Sales in the consumer health business grew 5.7%. Over-the-counter products like Tylenol and another analgesic Motrin as well as Aveeno skin and beauty care products all gained.

General surgery, surgical vision products and contact lenses in vision and hip and knee implants took sales of medical devices higher by 7.6% as people tended to ailments they had kept in abeyance during the pandemic.

Sales in the third quarter grew by some 11% both on a reported and adjusted basis. Adjusted earnings per share rose 18% to $2.60.

J&J Gains on Lifting Forecast Even as Vaccine Sales Seen Unchanged
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (2)
King Good
King Good Oct 19, 2021 8:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I love that
Felipe Daniel
Felipe Daniel Oct 19, 2021 8:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
J and J received legal immunity from Congress for vaccines, this means company takes no risk at all they will make fat profits but cannot be held accountable is something goes wrong.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email